
Dechra Pharmaceuticals PLC
LSE:DPH

Fundamental Analysis


Revenue & Expenses Breakdown
Dechra Pharmaceuticals PLC
Balance Sheet Decomposition
Dechra Pharmaceuticals PLC
Current Assets | 467.9m |
Cash & Short-Term Investments | 74.4m |
Receivables | 176.2m |
Other Current Assets | 217.3m |
Non-Current Assets | 1.1B |
Long-Term Investments | 14.9m |
PP&E | 159.3m |
Intangibles | 922.4m |
Other Non-Current Assets | 4.9m |
Free Cash Flow Analysis
Dechra Pharmaceuticals PLC
GBP | |
Free Cash Flow | GBP |
Earnings Waterfall
Dechra Pharmaceuticals PLC
Revenue
|
761.5m
GBP
|
Cost of Revenue
|
-331.9m
GBP
|
Gross Profit
|
429.6m
GBP
|
Operating Expenses
|
-404.7m
GBP
|
Operating Income
|
24.9m
GBP
|
Other Expenses
|
-52.8m
GBP
|
Net Income
|
-27.9m
GBP
|
DPH Profitability Score
Profitability Due Diligence
Dechra Pharmaceuticals PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Dechra Pharmaceuticals PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.
DPH Solvency Score
Solvency Due Diligence
Dechra Pharmaceuticals PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Dechra Pharmaceuticals PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DPH Price Targets Summary
Dechra Pharmaceuticals PLC
Dividends
Current shareholder yield for DPH is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?